Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dovato
Pharma
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Pfizer has surrendered its 11.7% interest in GSK's ViiV for $1.875B. Shionogi will pick up the shares $2.125B and take a 21.7% stake in ViiV.
Kevin Dunleavy
Jan 20, 2026 10:15am
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am
ViiV brings together sons and mothers in new initiative for HIV
May 30, 2023 7:15am
ViiV, Gilead row escalates to feds after self-regulation fails
May 2, 2023 10:14am
GSK changes direction with HIV prevention for Black women
Mar 23, 2023 7:45am
AbbVie's Skyrizi tops February's leading TV drug ad spenders
Mar 7, 2023 11:10am
